Works matching IS 10538569 AND DT 2023 AND VI 32 AND IP 2
Results: 14
Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof‐of‐concept analysis on the association between valproate and spina bifida.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 148, doi. 10.1002/pds.5573
- By:
- Publication type:
- Article
Associations of prenatal exposure to non‐steroidal anti‐inflammatory drugs with preterm birth and small for gestational age infants among women with autoimmune disorders.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 225, doi. 10.1002/pds.5570
- By:
- Publication type:
- Article
Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 158, doi. 10.1002/pds.5568
- By:
- Publication type:
- Article
High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 93, doi. 10.1002/pds.5566
- By:
- Publication type:
- Article
Trends and regional variations in prescriptions dispensed to stimulate uterine contractions at the end of pregnancy in Belgium: A community‐based study from 2003 to 2018.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 216, doi. 10.1002/pds.5558
- By:
- Publication type:
- Article
Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 256, doi. 10.1002/pds.5554
- By:
- Publication type:
- Article
A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 107, doi. 10.1002/pds.5550
- By:
- Publication type:
- Article
Anti‐osteoporosis medication dispensing by clinical commissioning groups in England – an ecological study of variability in practice and of the effect of the Covid‐19 pandemic.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 248, doi. 10.1002/pds.5544
- By:
- Publication type:
- Article
Medicine use in children aged under 12 years—Population survey in Finland.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 266, doi. 10.1002/pds.5539
- By:
- Publication type:
- Article
Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi‐stakeholder cross‐sectional study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 137, doi. 10.1002/pds.5538
- By:
- Publication type:
- Article
Antibiotic utilisation in primary and revision total hip replacement patients: A registry linkage cohort study of 106 253 patients using the Australian Orthopaedic Association National Joint Replacement Registry.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 238, doi. 10.1002/pds.5522
- By:
- Publication type:
- Article
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 126, doi. 10.1002/pds.5512
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 277, doi. 10.1002/pds.5456
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 1, doi. 10.1002/pds.5455
- Publication type:
- Article